TGFB1 and focal segmental glomerulosclerosis: The chronic administration of CsA mainly induces nephrotubular injury through increases in TGF-β1 and is associated with arteriole degeneration, focal glomerulosclerosis, and interstitial fibrosis due to hyperfiltration with a decreased number of nephrons [20,21].